Shizim Group

Shizim Group is an Israeli-based integrated holding group that specializes in Life Sciences and Health Technology. Founded in 2000 by Yossi Bornstein, the company operates in 13 countries and is deeply engaged in the biomedical ecosystem both in Israel and globally. The group focuses on several key areas, including the innovation and commercialization of medical devices and digital health technologies. It offers full-service Contract Research Organization (CRO) capabilities to support clinical research and regulatory affairs for pharmaceutical and medical device companies. Shizim also markets and distributes products for multinational corporations and provides advanced education and training programs in collaboration with the Technion (Israel Institute of Technology). Additionally, the group is involved in medical cannabis through investment, research, and management of medical farms. Shizim Group has a diverse portfolio that includes companies in MedTech, clinical studies, and continuing medical education. It has notable achievements, such as taking Microbot Medical public on NASDAQ and securing FDA and CE approvals for XACT Robotics. With a workforce of approximately 100-200 employees, Shizim Group is recognized for its comprehensive ecosystem that integrates innovation, research, and commercialization in the life sciences and health technology sectors.

• Employees 74